Studies on the chemotherapy of malaria. II. Pyrimethamine resistance in The Gambia.
D002353:Carrier State / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003622:Dapsone / Q000008:administration & dosage; D004352:Drug Resistance, Microbial; D004912:Erythrocytes; D005260:Female; D005714:Gambia; D006801:Humans; D007223:Infant; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D010963:Plasmodium falciparum / Q000187:drug effects / Q000254:growth & development; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use*; D013449:Sulfonamides / Q000008:administration & dosage
D013449:Sulfonamides; D003622:Dapsone; D002727:Proguanil; D011739:Pyrimethamine